Tsuda Kazushi, Tsuda Seiko, Nishio Ichiro
Department of Medicine, Wakayama Medical University, Wakayama, Japan.
J Cardiovasc Pharmacol. 2003 Dec;42 Suppl 1:S81-5. doi: 10.1097/00005344-200312001-00018.
There has been much evidence showing that the central sympathetic nervous system may be involved in the control of blood pressure. In the present study, we investigated the role of the presynaptic alpha2-adrenergic receptors and the cyclic adenosine monophosphate-dependent protein kinase (protein kinase A) in the regulation of norepinephrine release in the central nervous system in hypertension. The alpha2-adrenergic receptor agonists UK 14, 304 and clonidine inhibited the stimulation-evoked [3H]norepinephrine release in a dose-dependent manner in the medulla oblongata of Sprague-Dawley rats. Pretreatment of pertussis toxin (a potent inhibitor of the Gi-protein) attenuated the suppression of NE release by UK 14, 304. The protein kinase A inhibitor H-8 also reduced the stimulation-evoked [3H]norepinephrine release in rat medulla oblongata. In spontaneously hypertensive rats, the inhibitory effect of UK 14, 304 on the stimulation-evoked norepinephrine release was significantly less than in age-matched normotensive Wistar-Kyoto rats. By contrast, the protein kinase A inhibitor H-8 reduced the stimulation-evoked norepinephrine release to a greater extent in hypertension than in normotensive controls. The results of the present study showed that the alteration in the presynaptic alpha2-receptor-protein kinase A system might actively participate in the regulation of norepinephrine release in the central nervous system in hypertension.
有许多证据表明,中枢交感神经系统可能参与血压控制。在本研究中,我们调查了突触前α2 - 肾上腺素能受体和环磷酸腺苷依赖性蛋白激酶(蛋白激酶A)在高血压中枢神经系统中去甲肾上腺素释放调节中的作用。α2 - 肾上腺素能受体激动剂UK 14,304和可乐定在Sprague - Dawley大鼠延髓中以剂量依赖性方式抑制刺激诱发的[3H]去甲肾上腺素释放。百日咳毒素(Gi蛋白的有效抑制剂)预处理减弱了UK 14,304对NE释放的抑制作用。蛋白激酶A抑制剂H - 8也减少了大鼠延髓中刺激诱发的[3H]去甲肾上腺素释放。在自发性高血压大鼠中,UK 14,304对刺激诱发的去甲肾上腺素释放的抑制作用明显小于年龄匹配的正常血压Wistar - Kyoto大鼠。相比之下,蛋白激酶A抑制剂H - 8在高血压中比在正常血压对照中更大程度地减少了刺激诱发的去甲肾上腺素释放。本研究结果表明,突触前α2受体 - 蛋白激酶A系统的改变可能积极参与高血压中枢神经系统中去甲肾上腺素释放的调节。